Drug Profile

Cyclobenzaprine/etoricoxib - Eurofarma

Alternative Names: Cyclobenzaprine hydrochloride - Eurofarma

Latest Information Update: 15 Mar 2024

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Eurofarma
Class Amines; Analgesics; Antirheumatics; Anxiolytics; Dibenzocycloheptenes; Muscle relaxants; Non-opioid analgesics; Pyridines; Small interfering RNA; Sulfones
Mechanism of Action Cyclo-oxygenase 2 inhibitors

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

28 Feb 2024 Eurofarma withdrew phase-III BENCOX trial before enrollment in Postoperative pain (In adults) in Brazil (PO) due to change in study strategy (NCT05683574)
16 Jan 2023 Preclinical trials in Postoperative pain in Brazil (PO)
13 Jan 2023 Eurofarma plans the phase-III BENCOX trial for Pain in Brazil in June 2024 (NCT05683574)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com